Introducing robot-assisted laparoscopic donor nephrectomy after experience in retroperitoneal endoscopic approach: a matched propensity score analysis.

Autor: Thai MS; Urology Department, Cho Ray Hospital, Ho Chi Minh City, Viet Nam.; Urology Department, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam., Chau QT; Urology Department, Cho Ray Hospital, Ho Chi Minh City, Viet Nam., Hoang KC; Urology Department, Cho Ray Hospital, Ho Chi Minh City, Viet Nam., Ngo XT; Urology Department, Cho Ray Hospital, Ho Chi Minh City, Viet Nam.; Urology Department, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam., Tran TT; Urology Department, Cho Ray Hospital, Ho Chi Minh City, Viet Nam., Nguyen TH; Urology Department, Cho Ray Hospital, Ho Chi Minh City, Viet Nam., Thai KL; Urology Department, Cho Ray Hospital, Ho Chi Minh City, Viet Nam.; Urology Department, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam., Vu DH; Urology Department, Cho Ray Hospital, Ho Chi Minh City, Viet Nam., Dinh LQV; Urology Department, Cho Ray Hospital, Ho Chi Minh City, Viet Nam.; Urology Department, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam., Pham DM; Urology Department, Cho Ray Hospital, Ho Chi Minh City, Viet Nam.; Urology Department, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam., Tiong HY; Urology Department, National University Hospital, Singapore., Nguyen TT; Urology Department, Cho Ray Hospital, Ho Chi Minh City, Viet Nam.; Urology Department, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
Jazyk: angličtina
Zdroj: ANZ journal of surgery [ANZ J Surg] 2022 Mar; Vol. 92 (3), pp. 531-537. Date of Electronic Publication: 2021 Dec 19.
DOI: 10.1111/ans.17424
Abstrakt: Objectives: To assess the safety and efficacy of introducing robotic-assisted laparoscopic donor nephrectomy (RALDN) to the standard retroperitoneal endoscopic donor nephrectomy (REDN).
Methods: Data were collected prospectively from 124 consecutive living kidney donors (93 for REDN subgroup and 31 for RALDN subgroup) from February 2018 to December 2020. Donor baseline demographics, perioperative outcomes and recipient outcomes were recorded, and these parameters were compared between the two subgroups before and after propensity-score matching.
Results: Mean age was 51.1 ± 9.1 years; 42.7% were males; mean body mass index was 22.7 ± 2.4; and there were 109 (88%) left kidneys. The following data of REDN and RALDN was, respectively, recorded: operative time (213 ± 43 versus 216 ± 39 min, p = 0.721), warm ischemic time (4.7 ± 1.2 versus 4.9 ± 1.4 min, p = 0.399), postoperative complications (5.4% versus 6.5%, p = 1), haemoglobin (g/L) drop (9.4 ± 7.2 versus 9.7 ± 6.6, p = 0.836), blood creatinine at 6 month (1.15 ± 0.23 versus 1.13 ± 0.24 mg/dL, p = 0.734) and at 1 year (1.09 ± 0.22 versus 1.17 ± 0.28 mg/dL, p = 0.591). In post-propensity score matched analyses, there was no significant differences between the two groups including intraoperative and postoperative complications.
Conclusions: RALDN could be safely introduced into a living donor program experienced in laparoscopic donor nephrectomy. The outcomes of our study comparing these minimally invasive techniques are mostly similar in terms of intraoperative and postoperative outcomes for kidney donors.
(© 2021 Royal Australasian College of Surgeons.)
Databáze: MEDLINE
Externí odkaz: